GMP production of [18F]FE-PE2I on a TRACERLab FX2 N synthesis module, a radiotracer for in vivo PET imaging of the dopamine transport

• Egile Nagusiak: Mélodie Ferrat (Egilea), Mohammad M. Moein (Egilea), Carmen Cananau (Egilea), Tetyana Tegnebratt (Egilea), Paul Saliba (Egilea), Fredrik Norman (Egilea), Carsten Steiger (Egilea), Klas Bratteby (Egilea), Erik Samén (Egilea), Kenneth Dahl (Egilea), Thuy A. Tran (Egilea)
• Formatua: Liburua
• Argitaratua: SpringerOpen, 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Parkinson's disease is a neurodegenerative disorder that is characterized by a degeneration of the dopaminergic system. Dopamine transporter (DAT) positron emission tomography (PET) imaging has emerged as a powerful and non-invasive method to quantify dopaminergic function i...